# Cadrenal Therapeutics, Inc. (CVKD)

> Source: Nexqual · https://nexqual.com/CVKD · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Cadrenal Therapeutics, Inc. (CVKD), nexqual.com/CVKD" · informational, not investment advice.

**Price:** USD 0.97 (-4.90% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.02 · day 0.97–1.03 · 52w 0.82–14.21 · market cap $3.5M · NCM

## Key facts
- Total return with dividends: 1Y -93.0% vs S&P 500 +18.1%; 5Y -98.4% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2023-01-16) |
|---|---|---|
| Total return | -93.0% | -98.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -93.0% | -67.0% |
| Volatility (annualized) | 102.5% | 94.2% |
| Max drawdown | -93.8% (Oct 2025→Oct 2026) | -98.5% (Jan 2023→Oct 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/CVKD · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt